Bacterial News and Research

RSS

New technique could help fight the global threat of antibiotic resistance

A new technique could help reduce antibiotic prescribing by predicting which drugs could be effective in fighting bacteria within minutes.

2 Jul 2020

Researchers unravel how the body fights off urinary tract infections

Anyone who has ever had cystitis knows that urinary tract infections of this kind are annoying and painful. They can be well treated by antibiotics, but may be fatal if left untreated.

2 Jul 2020

Novel microbiome-based diagnostic tool can identify liver fibrosis, cirrhosis

Chronic liver disease represents a major global public health problem affecting an estimated 844 million people, according to the World Health Organization. It is among the top causes of mortality in Australia, the UK and the United States.

2 Jul 2020

Which facemasks work best at stopping coronavirus?

A new study shows how wearing masks can prevent the spread of droplet borne infections and is an excellent preventive measure to stop the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study titled, "Visualizing the effectiveness of face masks in obstructing respiratory jets," is published in the latest issue of the journal Physics of Fluids.

1 Jul 2020

Irresistin: a ‘poison arrow’ to defeat antibiotic resistance

News-Medical speaks to Dr. James Martin and Dr. Zemer Gitai from Princeton University about their research which led to the discovery of a new antibiotic.

1 Jul 2020

Study reveals a new target for tuberculosis drug development

Biology students and faculty members from The University of Texas at El Paso have discovered a new target for tuberculosis drug development.

1 Jul 2020

Oral hygiene and severity of COVID-19 – the connection

Their study titled, “Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?” was published in the latest issue of the journal British Dental Journal.

30 Jun 2020

New approach holds incredible potential for developing new therapeutics

Nearly every drug that is, or has ever been, used was derived from nature -- harnessing compounds created by organisms over eons to fight diseases. But decades ago, biochemists postulated that it might be possible to design a new drug from scratch by linking up amino acids in precise ways.

30 Jun 2020

New vaccination strategy targets toxic molecules released by all Staphylococcal bacteria

Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.

30 Jun 2020

High fiber diet may improve the quality of life for patients with ulcerative colitis

Eating diets low in fat and high in fiber may improve the quality of life of patients with ulcerative colitis (UC) - even those in remission.

30 Jun 2020

Wearable technology for health-related applications

There is more than cool looks about hip clothing for top performance: Thanks to a variety of smart technologies, high-tech clothing today is capable of analyzing body functions or actively optimizing the microclimate.

29 Jun 2020

Antibiotic resistance genes tend to persist in E. coli through 'genetic capitalism'

We have known for some time that over-use of antibiotics is causing a frightening increase in antibiotic resistance in bacteria, through the rapid spread of antibiotic resistance genes.

29 Jun 2020

Synoicum adareanum shows new possibilities for developing melanoma-specific drug

Could the cure for melanoma - the most dangerous type of skin cancer - be a compound derived from a marine invertebrate that lives at the bottom of the ocean?

26 Jun 2020

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

Researchers have developed a method to spur the production of new antibiotic or antiparasitic compounds hiding in the genomes of actinobacteria, which are the source of drugs such as actinomycin and streptomycin and are known to harbor other untapped chemical riches.

25 Jun 2020

Biological therapy may decrease the risk of severe COVID-19

A recent observational study by Spanish researchers, currently available on the medRxiv preprint server, suggests that patients with immune-mediated diseases who receive biological therapy may have a lower risk for severe manifestations of coronavirus disease (COVID-19).

25 Jun 2020

Superbug hijacks the wound healing system to cause serious and persistent disease

Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.

25 Jun 2020

Scientists pinpoint mutations that increase bacterial deadliness

As far as humans are concerned, bacteria can be classified as either harmful, pathogenic bacteria and harmless or beneficial non-pathogenic bacteria.

25 Jun 2020

Study finds entry point for curbing the evolution of antibiotic resistance

The team of Professor Tobias Bollenbach from the Institute for Biological Physics at the University of Cologne has published a study on a new approach to improving the effectiveness of antibiotics in bacterial infections.

24 Jun 2020

Bacteriophage could help decrease mortality of patients with COVID-19

Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up. This could decrease the mortality of patients affected by COVID-19, according to the peer-reviewed journal PHAGE: Therapy, Applications, and Research.

24 Jun 2020

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.

24 Jun 2020

Bacterial News and Research

New technique could help fight the global threat of antibiotic resistance

Researchers unravel how the body fights off urinary tract infections

Novel microbiome-based diagnostic tool can identify liver fibrosis, cirrhosis

Which facemasks work best at stopping coronavirus?

Irresistin: a ‘poison arrow’ to defeat antibiotic resistance

Study reveals a new target for tuberculosis drug development

Oral hygiene and severity of COVID-19 – the connection

New approach holds incredible potential for developing new therapeutics

New vaccination strategy targets toxic molecules released by all Staphylococcal bacteria

High fiber diet may improve the quality of life for patients with ulcerative colitis

Wearable technology for health-related applications

Antibiotic resistance genes tend to persist in E. coli through 'genetic capitalism'

Synoicum adareanum shows new possibilities for developing melanoma-specific drug

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

Biological therapy may decrease the risk of severe COVID-19

Superbug hijacks the wound healing system to cause serious and persistent disease

Scientists pinpoint mutations that increase bacterial deadliness

Study finds entry point for curbing the evolution of antibiotic resistance

Bacteriophage could help decrease mortality of patients with COVID-19

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News